Over 10,000 results
Page 5 of 100
8-K
rziah822d0yeedzejld
29 May 24
VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients
8:00am
6-K
EX-99.1
5arhjcok
29 May 24
Current report (foreign)
6:29am
6-K
EX-99.1
2wghya 8tx
29 May 24
Current report (foreign)
6:29am
6-K
EX-99.1
rohilpbo72891jh7
29 May 24
Current report (foreign)
6:24am
F-1
ont9 is5b5
28 May 24
Registration statement (foreign)
9:37pm
F-1
EX-10.1
yn2uy kjtooh4d
28 May 24
Registration statement (foreign)
9:37pm
6-K
EX-99.1
7z1csaqd16x2varx2n
28 May 24
CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK
4:56pm
6-K
EX-99.1
1iq7mq
28 May 24
Current report (foreign)
4:16pm
18-K/A
EX-9
zvjeuto4vza2dk73rc4
28 May 24
Annual report (foreign governments) (amended)
4:01pm
6-K
EX-99.3
owigl7 z27rf3
28 May 24
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines
12:04pm
6-K
EX-99.5
h7cswj6i5 xoc2obu9
28 May 24
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines
12:04pm
6-K
EX-99.1
8og 3f38pejnkj7if
28 May 24
Evaxion Announces Business Update and First Quarter 2024 Financial Results
9:30am
S-1/A
qlj 9lpgud
28 May 24
IPO registration (amended)
8:05am
424B5
5w0tsprirzmj 6mq
24 May 24
Prospectus supplement for primary offering
4:58pm
8-K
EX-99.1
rr47j47uxm3oaksiaii
24 May 24
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
4:05pm
8-K
EX-99.1
gh9y2inx
24 May 24
Other Events
10:19am
N-CSRS
t0nwfg95kt7u l0
24 May 24
Certified semi-annual shareholder report (management investment company)
10:00am